Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02346708 · ClinicalTrials.gov registry record · NA
Cognitive Dysfunction in Parkinson's Disease
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT02346708: Completed NA study, sponsored by University of Colorado, Denver.
NCT02346708 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02346708, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
This study plans to learn more about the brain function related to thinking problems in individuals with Parkinson's disease.
Primary Outcome
Our MEG outcome will be a change in small-worldness, global efficiency, nodal efficiency and degree distribution pre-TMS to immediately post-TMS treatment.
Interventions
- DEVICE Sham TMS
- DEVICE Real TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2014-01 |
| Est. Completion | 2020-12 |
| Phase | NA |
What the finished NCT02346708 record still lists
NCT02346708 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham TMS is the first listed.
NCT02346708 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02346708 about?
NCT02346708 is a clinical study titled "Cognitive Dysfunction in Parkinson's Disease". This study plans to learn more about the brain function related to thinking problems in individuals with Parkinson's disease.
What is the current status of trial NCT02346708?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2014-01. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02346708?
The interventions under investigation include: Sham TMS (DEVICE), Real TMS (DEVICE).
Who is sponsoring clinical trial NCT02346708?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02346708's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia